Reuters logo
BRIEF-Veloxis Pharmaceuticals signs deal with Chiesi Farmaceutici to commercialize Envarsus XR in China
June 6, 2017 / 5:11 AM / 4 months ago

BRIEF-Veloxis Pharmaceuticals signs deal with Chiesi Farmaceutici to commercialize Envarsus XR in China

June 6 (Reuters) - VELOXIS PHARMACEUTICALS A/S

* ANNOUNCES AGREEMENT WITH CHIESI FARMACEUTICI S.P.A. TO COMMERCIALIZE ENVARSUS XR IN CHINA

* SUBSIDIARY VELOXIS PHARMACEUTICALS, INC., ENTERS EXCLUSIVE LICENSE, SUPPLY AND DISTRIBUTION DEAL

* DEAL WITH CHIESI FARMACEUTICI TO REGISTER, COMMERCIALIZE AND DISTRIBUTE ENVARSUS XR IN CHINA AND TAIWAN

* VELOXIS WILL RECEIVE AN UP-FRONT PAYMENT IN AMOUNT OF USD 6 MILLION AND A MILESTONE PAYMENT UPON APPROVAL

* INITIAL TERM OF AGREEMENT IS FOR A PERIOD OF 15 YEARS FROM EFFECTIVE DATE OF AGREEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below